Amnion nodosum

From WikiMD's Medical Encyclopedia

Revision as of 06:10, 10 February 2025 by Prab (talk | contribs) (CSV import)

Amnion Nodosum is a pathological condition that affects the amnion, the innermost layer of the placenta. It is characterized by the presence of nodules or granules on the amniotic surface of the placenta. These nodules are typically composed of squamous cells that have been shed from the fetus.

Etiology

The exact cause of amnion nodosum is not well understood. However, it is often associated with oligohydramnios, a condition characterized by a deficiency of amniotic fluid. This association suggests that amnion nodosum may be a response to an abnormal intrauterine environment.

Pathogenesis

The nodules in amnion nodosum are believed to be formed by the accumulation of squamous cells that have been shed from the fetal skin. These cells may accumulate due to a lack of amniotic fluid, which normally helps to disperse the cells throughout the amniotic cavity.

Clinical Significance

Amnion nodosum is often associated with poor fetal outcomes, including intrauterine growth restriction, premature birth, and stillbirth. However, it is not clear whether amnion nodosum is a cause of these outcomes, or simply a marker of an abnormal intrauterine environment.

Diagnosis

Amnion nodosum is typically diagnosed after birth, during examination of the placenta. The presence of nodules on the amniotic surface of the placenta is a characteristic finding.

Treatment

There is currently no specific treatment for amnion nodosum. Management is typically focused on addressing the underlying cause, such as treating oligohydramnios.

See Also

Stub icon
   This article is a medical stub. You can help WikiMD by expanding it!
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.